Molecular and cellular alterations in tobacco smoke-associated larynx cancer

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 445, Issue 2, 1999, Pages 259-274

  Szyfter, K ^a   Szmeja, Z ^b   Szyfter, W ^b   Hemminki, K ^c   Banaszewski, J ^b   Jaskula Sztul R ^a   Louhelainen, J ^c  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chromosome alteration; DNA adduct; Genetic risk; Laryngeal cancer; p53 mutation; Tobacco smoking

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL CYCLE; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DNA ADDUCT; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; LARYNX CANCER; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SMOKING; TUMOR SUPPRESSOR GENE; Y CHROMOSOME;

CARCINOMA, SQUAMOUS CELL; DNA ADDUCTS; DNA, NEOPLASM; FEMALE; GENES, P16; GENES, P53; HUMANS; LARYNGEAL NEOPLASMS; MALE; SMOKING;

EID: 0032705916     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00131-X     Document Type: Article

References (86)

1. Parkin D.M., Laara E., Muir C.S. Estimates of the world-wide frequency of sixteen major cancers in 1980s. Int. J. Cancer. 41:1988;184-197.
2. Ch.W. Cummings, J.M. Fredrickson, L.A. Hacker, Ch.J. Krause, D.E. Schuller (Eds.), Otolaryngology - Head and Neck Surgery, Vol. 3, 2nd edn., Mosby Year Book, St. Louis, 1993.
3. Worsham M.J., Wolman S.R., Carey T.E., Zarbo R.J., Benninger M.S., van Dyke D.L. Common clonal origin of synchronous primary HNSCC: analysis by tumour karyotypes and FISH. Hum. Pathol. 26:1995;251-261.
4. Bedi G.C., Westra W.H., Gabrielson E., Koch W., Sidransky D. Multiple head and neck tumours: evidence for a common clonal origin. Cancer Res. 56:1996;2484-2487.
5. Carey T.E. Field cancerization: are multiple primary cancers monoclonal or polyclonal? Ann. Med. 28:1996;183-188.
6. Zatoński W., Becher H., Lissowska J., Wahrendorf J. Tobacco, alcohol, and diet in the etiology of laryngeal cancer: a population-based case-control study. Cancer Causes and Control. 2:1991;3-10.
7. Choi S.Y., Kahyo H. Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int. J. Epidemiol. 20:1991;878-885.
8. Freudenheim J.L., Graham S., Byer T.E., Marshall J.R., Haughey B.G., Swanson M.K., Wilkinson G. Diet, smoking and alcohol in cancer of the larynx: a case-control study. Nutr. Cancer. 17:1992;33-45.
9. S.P.Schantz, N.K.Lee, Tobacco carcinogenesis and head and neck cancer, in: J.A. Werner, B.M. Lippert, H.H. Ruppert (Eds.), Head and Neck Cancer - Advances in Basic Research, Elsevier, Amsterdam, 1996, pp. 9-20.
10. IARC, Tobacco Smoking, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, IARC, Lyon, 1986.
11. Pauly J.L., Allaart H.A., Rodriquez M.I., Streck R.J. Fibres released from cigarette filters: an additional health risk to smoker? Cancer Res. 55:1995;253-258.
12. Muscat J.E., Wynder E.L. Tobacco, alcohol, asbestos and occupational risk factors for laryngeal cancer. Cancer. 69:1992;2244-2251.
13. Anwar K., Nakakuki K., Naiki H., Inuzuka M. ras gene mutations and HPV infection are common in human laryngeal carcinoma. Int. J. Cancer. 53:1993;22-28.
14. Chen Z., Storthz K.A., Shillitoe E.J. Mutations in the long control region of human HPV in oral cancer cells, and their functional consequences. Cancer Res. 57:1997;1614-1619.
15. Lisowska J., Zatoński W. Tumours of the larynx in Poland in comparison to other European countries. Etiological hypotheses. Otolaryngol. Pol. 46:1992;211-216.
16. Zatoński W., Tyczyński J., Didkowska J. Malignant tumours of the larynx in Poland in the years 1963-1989. Otolaryngol. Pol. 46:1992;203-210.
17. Z. Wronkowski, M. Zwierko, Malignant tumours in Poland, in: Clinical Oncology, UICC, Polish edition by PWN, Warsaw, 1994, addendum.
18. L. Tomatis (Ed.), Cancer: Causes, Occurrence and Control, IARC Scientific Publications, IARC, Lyon, 1990, pp. 52-64.
19. Hemminki K. DNA adducts, mutations and cancer. Carcinogenesis. 14:1993;2007-2012.
20. Phillips D.H. DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. Environ. Health Perspect. 104(4):1996;453-458. Suppl.
21. Stern S.J., Degawa M., Martin M.V., Guengerich F.P., Kaderlik R.K., Ilett K.F., Breau R., McGhee M., Montague D., Lyn-Cook B., Kadlubar F.F. Metabolic activation, DNA adducts, and h-ras mutations in human neoplastic and non-neoplastic laryngeal tissue. J. Cell. Biochem. 17F:1993;129-137. Suppl.
22. Szyfter K., Szmeja Z., Szyfter W. Analysis of DNA adducts in larynx cancer patients. Otolaryngol. Pol. 47:1993;496-501.
23. 32P -postlabelling assay Mutat. Res. 378:1997;1-12.
24. 32P -postlabelling analysis of DNA adducts in humans: adduct distribution and method improvement Mutat. Res. 313:1994;269-276.
25. Degawa M., Stern S.J., Martin M.V., Guengerich F.P., Fu P.F., Ilett K.F., Kaderlik R.K., Kadlubar F.F. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res. 54:1994;4915-4919.
26. 7-alkylguanine in DNA of larynx tissue and leucocytes. Carcinogenesis. 17:1996;501-506.
27. Li D., Wang M., Dhindhra K., Hittelman W.N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer aetiology. Cancer Res. 56:1996;287-293.
28. B. Schoket, S. Kostic, I. Vincze, Determination of smoking-related DNA adducts in lung-cancer and non-cancer patients, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Methods for Detection of DNA Adducts, IARC, Lyon, 1993, pp. 315-319.
29. Pfohl-Leszkowicz A., Grosse Y., Carriere V., Cugnenc P.H., Berger A., Carnot F., Beaune Ph., de Waziers I. High levels of DNA adducts in human colon are associated with colorectal cancer. Cancer Res. 55:1995;5611-5616.
30. Szyfter K., Hemminki K., Szyfter W., Szmeja Z., Banaszewski J., Yang K. Aromatic DNA adducts in larynx cancer biopsies and leukocytes. Carcinogenesis. 15:1994;2195-2199.
31. Friedberg E.C. Relationships between DNA repair and transcription. Ann. Rev. Biochem. 65:1996;15-42.
32. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., Corio R., Lee D., Greenberg B., Koch W., Sidransky D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56:1996;2488-2492.
33. van Schooten F.J., Hillebrand M.J.X., van Leeuven F.E., van Zandwijk N., Jansen H.M., den Engelse L., Kriek E. PAH-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. Carcinogenesis. 13:1992;987-993.
34. Baan R.A., Steenwinkel M.-J.S.T., van den Berg P.T.M., Roggeband R., van Delft J.H.M. Molecular dosimetry of DNA damage induced by PAH; relevance for exposure monitoring and risk assessment. Hum. Exp. Toxicol. 13:1994;880-887.
35. R.C. Garner, J. Cuzick, D. Jenkins, D.H. Phillips, A. Hewer, M.M. King, M.N. Routledge, Linear relationship between DNA adducts in human lung and cigarette smoking, in: H. Vainio, M. Sorsa, A.J. McMichael (Eds.), Complex Mixtures and Cancer Risk, IARC, Lyon, 1990, pp. 421-426.
36. Gaubatz J.W., Tan B.H. Age-related studies on the removal of 7-methylguanine from DNA of mouse kidney tissue following N-methyl-N-nitrosourea treatment. Mutat. Res. 295:1993;81-91.
37. Bohr V.A., Anson R.M. DNA damage, mutation and fine structure DNA repair in aging. Mutat. Res. 338:1995;25-34.
38. Szyfter W., Szmeja Z., Szyfter K., Banaszewski J., Kruk-Zagajewska A., Hemminki K. Estimation of aromatic DNA adducts level in larynx tumour in relation to cancer staging. Otolaryngol. Pol. 49:1994;410-417.
39. Szyfter K., Hemminki K., Jaskula-Sztul R., Banaszewski J., Szyfter W., Szmeja Z. Significance of DNA adduct studies in the early phase of carcinogenesis. Period. Biolog. 96:1994;345-347.
40. Szyfter K., Kruk-Zagajewska A., Szmeja Z., Kozak W., Kujawski M., Banaszewski J., Wójtowicz J. Sex-associated differential susceptibility of larynx to tobacco smoke carcinogens. Otolaryngol. Pol. 52:1998;153-158.
41. Ryberg D., Hewer A., Phillips D.H., Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res. 54:1994;5801-5803.
42. Phillips D.H., Schoket B., Hewer A., Bailey E., Kostic S., Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int. J. Cancer. 46:1990;569-575.
43. 32P -postlabelling Carcinogenesis. 18:1997;339-344.
44. Szmeja Z., Zagajewska-Kruk A., Kozak W., Szyfter W., Wójtowicz J. A correlation between clinical stage of laryngeal cancer and concentrations of sex hormones in blood. Otolaryngol. Pol. 50:1996;21-31.
45. Jin Y., Mertens F., Mandahl N., Heim S., Olegard C., Wennerberg J., Biörklund A., Mitelman F. Chromosome abnormalities in 83 head and neck squamous cell carcinomas: influence of culture conditions in karyotypic pattern. Cancer Res. 53:1993;2140-2146.
46. Jin Ch., Jin Y., Wennerberg J., Akervall J., Grenthe B., Mandahl N., Heim S., Mitelman F., Mertens F. Clonal chromosome aberrations accumulate with age in upper aerodigestive tract mucosa. Mutat. Res. 374:1997;63-72.
47. Worsham M., Benninger M.J., Zarbo R.J., Carey T.E., van Dyke D.L. Deletion 9p22pter and loss of Y as primary chromosome abnormalities in a squamous cell carcinoma of the vocal cord. Genes, Chromosomes Cancer. 6:1993;58-60.
48. Harris C.C. Chemical and physical carcinogenesis: advances and perspectives for 1990s. Cancer Res. 51:1990;5023-5044. Suppl.
49. Sommers K.D., Merrick M.A., Lopez M.E., Incognito L.S., Schechter G.L., Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 52:1992;5997-6000.
50. Law J.C., Whiteside T.L., Gollin S.M., Weissfeld J., El-Ashmavy L., Srivastava S., Landreneau R.J., Johnson J.T., Ferrel R.E. Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract. Clin. Cancer Res. 1:1995;763-768.
51. Spruck Ch.H. III, Tsai Y.C., Huang D.P., Yang A.S., Rideaut W.M. III, Gonzales-Zulueta M., Choi P., Lo K.-W., Yu M.C., Jones P.A. Absence of p53 mutations in primary nasopharyngeal carcinomas. Cancer Res. 52:1992;4787-4790.
52. Zhang L.F., Hemminki K., Szyfter K., Szyfter W., Söderkvist P. p53 mutations in larynx cancer. Carcinogenesis. 15:1996;2949-2951.
53. Biggs P., Warren W., Venitt S., Stratton M.R. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis. 8:1993;275-283.
54. Anwar K., Nakakuki K., Imai H., Inuzuka M. Over-expression of p53 protein in human laryngeal carcinoma. Int. J. Cancer. 53:1993;952-956.
55. Bennett W.P., Colby T.V., Travis W.D., Borkowski A., Jones R.T., Lane D.P., Metcalf R.A., Samet J.M., Takeshima Y., Gu J.R., Vähäkangas K.H., Soini Y., Pääkkö P. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res. 53:1993;4817-4822.
56. Louhelainen J., Szyfter K., Szyfter W., Hemminki K. Loss of heterozygosity and microsatellite instability in larynx cancer. Int. J. Oncol. 10:1997;247-252.
57. Gonzales M.V., Pello M.F., Lopes-Larrea C., Suarez C., Menendez M.J., Coto E. LOH and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck. Clin. Cancer Res. 1:1995;1043-1049.
58. Liggett W.H. jr., Sewell D.A., Rocco J., Ahrendt S.A., Koch W., Sidransky D. p16 and p16β are potent growth suppressor of head and neck squamous cell carcinoma cells in vitro. Cancer Res. 56:1996;4119-4123.
59. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W., Ahrendt S., Eby Y., Sewell D., Nawroz H., Bartek J., Sidransky D. High frequency of p16 inactivation in head and neck squamous cell carcinoma. Cancer Res. 56:1996;3630-3633.
60. Harris C.C. p53 tumour suppressor gene: from the basic research laboratory to the clinic - an abridged historical perspective. Carcinogenesis. 17:1996;1187-1198.
61. Liu T.-J., Zhang W.-W., Taylor D.L., Roth J.A., Goepfert H., Clayman G.L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54:1994;3662-3667.
62. Overholt S.M., Liu T.-J., Taylor D.L., Wang M., El-Naggar A.K., Shillitoe S., Adler-Storthz K., St. John L., Zhang W.-W., Roth J.A., Clayman G.L. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG; a potential marker for gene therapy trials. Clin. Cancer Res. 3:1997;185-191.
63. Golusinski W., Olofsson J., Szmeja Z., Szyfter K., Szyfter W., Biczysko W., Hemminki K. Alteration of p53 gene structure and function in laryngeal squamous cell cancer. Eur. Arch. Otorhinolaryngol. 254(1):1997;S133-S137. Suppl.
64. Lavieille J.P., Brambilla E., Riva-Lavieiile C., Reyt E., Charachon R., Brambilla C. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol. (Stockholm). 115:1995;334-339.
65. Tomasino R.M., Daniele E., Bazan V., Morello V., Tralongo V., Nuara R., Nagar C., Salvato M., Ingria F., Restivo S., Dardanomi G., Vecchione A., Russo A. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. Cancer Res. 55:1995;6103-6108.
66. Franchi A., Gallo O., Boddi V., Santucci M. Prediction of occult neck metastases in laryngeal carcinoma: role of PCNA, MIB-1, and E-cadherin immunohistochemical determination. Clin. Cancer Res. 2:1996;1801-1808.
67. Copper M.P., Jovanovic A., Nauta J.J.P., Braakhuis B.J.M., de Vries N., van der Waal I., Snow G.B. Role of genetic factors in the aetiology of squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 121:1995;157-160.
68. Foulkes W.D., Brunet J.S., Kowalski L.P., Narod S.A., Franco E.L. Family history of cancer is a risk factor for scc of the head and neck in Brazil; a case-control study. Int. J. Cancer. 63:1995;769-773.
69. Foulkes W.D., Brunet J.S., Sieh W., Black M.J., Shenouda G., Narod S.A. Familial risk of scc of head and neck: retrospective case-control study. Br. Med. J. 313:1996;716.
70. Janot F., Massad L., Ribrag V., de Waziers I., Beaune Ph.H., Luboinski B., Parise O. Jr., Gouyette A., Chabot G.G. Principal xenobiotic metabolizing enzyme systems in human head and neck squamous cell carcinoma. Carcinogenesis. 14:1993;1279-1283.
71. Hirvonen A. Combination of susceptible genotypes and individual responses to toxicants. Environ. Health Perspect. 105:1997;755-758.
72. K. Hemminki, Interindividual variation in the level of DNA and protein adducts in humans, in: Ecogenetics, Chapman & Hall, London, 1991, pp. 217-234.
73. Tlsty T.D., Briot A., Gualberto A., Hall I., Hess S., Hixon M., Kuppuswamy D., Romanov S., Sage M., White A. Genomic instability and cancer. Mutat. Res. 337:1995;1-7.
74. Wiencke J.K., Spitz M.R. In vitro chromosomal assays of mutagen sensitivity and human cancer risk. Cancer Bull. 46:1994;238-246.
75. Hsu T.C. Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell Dev. Biol. 23:1987;591-603.
76. Spitz M.P., Fueger J.J., Halabi S., Schantz S.P., Sample D., Hsu T.C. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol., Biomarkers Prev. 2:1993;329-333.
77. Da̧browski P., Pia̧tkowski K., Kita S., Szyfter K., Szmeja Z., Szyfter W. Chromosome sensitivity to bleomycin-induced damage in larynx cancer as a marker of genetic risk. Otolaryngol. Pol. 52:1998;245-250.
78. Cloos J., Braakhuis B.J.M., Steen I., Cooper M.P., de Vries N., Nauta J.J.P., Snow G.B. Increased mutagen sensitivity in head and neck scc patients, particularly those with multiple primary tumours. Int. J. Cancer. 56:1994;816-819.
79. D'Erricco A., Taioli A., Chen X., Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of literature. Biomarkers. 1:1996;149-173.
80. Seidegard J., Ekstrom G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ. Health Perspect. 105(4):1997;791-798. Suppl.
81. Bongers V., Snow G.B., Braakhuis B.J.M. The role of glutathione-S-transferases in head and neck scc. Oral Oncol. 31B:1995;349-354.
82. R. Jaskula-Sztul, A. Hirvonen, K. Husgafvel-Pursiainen, Z. Szmeja, W. Szyfter, K. Szyfter, Glutathione-S-transferase genotypes as modifiers of individual susceptibility to smoking-related larynx cancer, in: J.A. Werner, B.M. Lippert, H.H. Ruppert (Eds.), Head and Neck Cancer - Advances in Basic Research, Elsevier, Amsterdam, 1996, pp. 29-33.
83. Jaskula-Sztul R., Reinekainen M., Husgafvel-Pursiainen K., Szmeja Z., Szyfter W., Szyfter K., Hirvonen A. Glutathione-S-transferase M1 and T1 genotypes and susceptibility to smoking related larynx cancer. Biomarkers. 3:1998;149-155.
84. Brockmöller J., Kerb R., Drakoulis N., Staffeld B., Roots I. GST M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res. 54:1994;4103-4111.
85. Szyfter K., Jaskula-Sztul R., Banaszewski J., Möller L., Szyfter W., Szmeja Z. Analysis of genotypes of detoxifying enzymes demonstrates a significance of genetic factor in laryngeal cancer. Wsp. Onkol. 7:1998;159-161. in Polish.
86. W.M. Koch, Molecular biology of head and neck tumours, in: Ch.W. Cummings, J.M. Fredrickson, L.A. Hacker, Ch.J. Krause, D.E. Schuller (Eds.), Otolaryngology - Head and Neck Surgery, 2nd edn., Mosby, St. Louis, 1995, pp. 35-50.